Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (abre nova janela)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Fonte‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Indexado‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (abre nova janela)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (abre nova janela)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Fonte‎: Cochrane Database Syst Rev 2018;4:CD011689.

Indexado‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (abre nova janela)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (abre nova janela)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Fonte‎: Am J Obstet Gynecol.

Indexado‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (abre nova janela)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (abre nova janela)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Fonte‎: S Afr Med J 2016;106(4):399-402.

Indexado‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (abre nova janela)

Prophylactic use of ergot alkaloids in the third stage of labour. (abre nova janela)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Fonte‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Indexado‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (abre nova janela)

Treatment for primary postpartum haemorrhage. (abre nova janela)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Fonte‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Indexado‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (abre nova janela)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (abre nova janela)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Fonte‎: Obstet Gynecol 2001;98(3):386-90.

Indexado‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (abre nova janela)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (abre nova janela)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Fonte‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Indexado‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (abre nova janela)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (abre nova janela)

Ragab A, Barakat R, Alsammani MA.

Fonte‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Indexado‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (abre nova janela)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (abre nova janela)

Roach MK, Abramovici A, Tita AT.

Fonte‎: Am J Perinatol 2013;30(7):523-8.

Indexado‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (abre nova janela)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (abre nova janela)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Fonte‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Indexado‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (abre nova janela)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (abre nova janela)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Fonte‎: Lancet Glob Health. 2023 11(2):e287-e295.

Indexado‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (abre nova janela)

Intravenous sulprostone infusion in the treatment of retained placenta. (abre nova janela)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Fonte‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Indexado‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (abre nova janela)

Carbetocin for preventing postpartum haemorrhage. (abre nova janela)

Su LL, Chong YS, Samuel M.

Fonte‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Indexado‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (abre nova janela)

Prostaglandins for preventing postpartum haemorrhage. (abre nova janela)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Fonte‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Indexado‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (abre nova janela)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (abre nova janela)

Westhoff G, Cotter AM, Tolosa JE.

Fonte‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Indexado‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (abre nova janela)